Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongmai Jiangtang Capsules for CV Risk in Metabolic Syndrome
NCT06908473Phase 3Enrolling by invitation
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Apr 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tongmai Jiangtang Capsule in metabolic syndrome, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Started Apr 2025; status: enrolling by invitation.
02
Drugs
Tongmai Jiangtang Capsule
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT06908473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06908473.